19 unknown. 19 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Unknown 19 |
| Phase 2 | 4 | Unknown 4 |
Follow Deglutition Disorders: new trials by email Literature Review of Deglutition Disorders trials Research Report on Deglutition Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) DWP14012 20mg, DWP14012 40mg, Placebo - Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 324 | 2023-08-31 | 2023-11-08 |
| The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers Esomeprazole Magnesium Enteric-coated Tablets, Lifestyle adjustment - Gastroesophageal Reflux Disease | Phase 3 | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 92 | 2021-07-01 | 2021-01-06 |
| Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia One dose of Cefo-perazone Sulbactum - Achalasia Cardia | Phase 3 | Unknown | Asian Institute of Gastroenterology, India | 40 | 2018-12-01 | 2020-01-18 |
| Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia Saline Solution, Ceftazidime - Esophageal Achalasia | Phase 2 / Phase 3 | Unknown | Shanghai Zhongshan Hospital | 666 | 2017-10-01 | 2018-11-07 |
| Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease Melanole for GERD treatment, Placebo - GERD | Phase 2 / Phase 3 | Unknown | Lebanese American University | 170 | 2015-10-01 | 2015-10-28 |
| STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD Radio Frequency Ablation (RFA) (Stretta Procedure), Sham Procedure - GERD | Phase 3 | Unknown | Asian Institute of Gastroenterology, India | 20 | 2015-01-01 | 2016-10-18 |
| S-pantoprazole 10mg Phase III Clinical Study S-pantoprazole 10mg, Placebo - Non Erosive Reflux Disease | Phase 3 | Unknown | Ahn-Gook Pharmaceuticals Co.,Ltd | 174 | 2014-10-01 | 2014-10-27 |
| Laparoscopic Repair of Giant Hiatal Hernias With Nitinol-framed Lightweight Polytetrafluoroethylene Mesh Nitinol-framed lightweight PTFE mesh for hiatal repair, Partially absorbable lightweight mesh for hiatal repair - Hernia, Hiatal | Phase 3 | Unknown | Odessa National Medical University | 50 | 2013-06-01 | 2016-06-30 |
| Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer Brachytherapy, Endoscopic stenting - Adenocarcinoma of the Esophago-gastric Junction | Phase 2 / Phase 3 | Unknown | Medical University of Lublin | 80 | 2013-02-01 | 2013-02-07 |
| Laparoscopic Lightweight Mesh Repair of Large Hiatal Hernias Laparoscopic hiatal repair with sub-lay partially absorbable lightweight mesh, Laparoscopic primary posterior crural repair - Hernia, Hiatal | Phase 3 | Unknown | Odessa National Medical University | 100 | 2013-01-01 | 2015-10-14 |
| Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers esophagojejunostomy after total gastrectomy, Roux-en-Y gastrojejunostomy after subtotal gastrectomy, wide tube reconstruction after subtotal gastrectomy - Stomach Neoplasms, Esophageal Neoplasms | Phase 3 | Unknown | West China Hospital | 60 | 2012-03-01 | 2016-09-13 |
| Early Percutaneous Tracheostomy and Swallowing Dysfunction Percutaneous tracheostomy, Prolonged translaryngeal intubation - Swallowing Disorder | Phase 3 | Unknown | University of Chile | 120 | 2011-01-01 | 2011-01-05 |
| Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy Billroth-I, Roux en Y - Gastrectomy | Phase 3 | Unknown | Ajou University School of Medicine | 120 | 2010-06-01 | 2011-11-07 |
| Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD Esomeprazole, esomeprazole - Gastroesophageal Reflux Disease | Phase 2 / Phase 3 | Unknown | Southern Arizona VA Health Care System | 20 | 2010-03-01 | 2010-08-19 |
| a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent novel stent, conventional covered stent - Esophageal Cancer | Phase 3 | Unknown | Southeast University, China | 180 | 2009-12-01 | 2012-04-02 |
| The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With Percutaneous Endoscopic Gastrostomy Placement Chlorhexidine gluconate 0.2%, Plain water - Dysphagia, Peristomal Wound Infection | Phase 3 | Unknown | Hillel Yaffe Medical Center | 50 | 2009-05-01 | 2009-03-11 |
| Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. Rozerem (ramelteon), placebo - Gastroesophageal Reflux Disease, Chronic Insomnia | Phase 3 | Unknown | Southern Arizona VA Health Care System | 40 | 2009-03-01 | 2011-05-12 |
| A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients Laparoscopic Nissen Fundoplication, Laparoscopic anterior partial fundoplication - Gastroesophageal Reflux Disease | Phase 3 | Unknown | Chinese University of Hong Kong | 100 | 2006-11-01 | 2007-05-30 |
| On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication pantoprazole 20 mg (drug) - Chronic Use of Acid Suppressive Medication, GORD | Phase 3 | Unknown | UMC Utrecht | 276 | 2004-03-01 | 2006-02-02 |
Gastroesophageal Reflux (11) · Esophageal Achalasia (2) · Esophageal Neoplasms (2) · Hernia, Hiatal (2) · Non-Erosive Reflux Disease (2) · Adenocarcinoma (1) · Heartburn (1) · Peptic Ulcer (1) · Sleep Initiation and Maintenance Disorders (1) · Stomach Neoplasms (1)
Digestive System Diseases (19) · Esophageal Diseases (19) · Gastrointestinal Diseases (19) · Esophageal Motility Disorders (15) · Otorhinolaryngologic Diseases (4) · Pharyngeal Diseases (4) · Neoplasms (3) · Pathological Conditions, Signs and Symptoms (3) · Digestive System Neoplasms (2) · Gastroesophageal Reflux (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Hernia (2) · Hernia, Diaphragmatic (2)
Esomeprazole (2) · Anastomosis, Roux-en-Y (1) · Brachytherapy (1) · Ceftazidime (1) · Gastric Bypass (1) · Gastroenterostomy (1) · Nigella sativa oil (1) · Pantoprazole (1) · Pharmaceutical Preparations (1) · Radiofrequency Ablation (1) · Saline Solution (1) · Sugars (1) · fexuprazan (1) · ramelteon (1)
Asian Institute of Gastroenterology, India (2) · Odessa National Medical University (2) · Southern Arizona VA Health Care System (2) · Ahn-Gook Pharmaceuticals Co.,Ltd (1) · Ajou University School of Medicine (1) · Chinese University of Hong Kong (1) · Daewoong Pharmaceutical Co. LTD. (1) · Fifth Affiliated Hospital, Sun Yat-Sen University (1) · Hillel Yaffe Medical Center (1) · Lebanese American University (1) · Medical University of Lublin (1) · Shanghai Zhongshan Hospital (1) · Southeast University, China (1) · UMC Utrecht (1) · University of Chile (1)
China (3) · South Korea (3) · India (2) · Ukraine (2) · United States (2) · Chile (1) · Hong Kong (1) · Lebanon (1) · Poland (1)
Ronnie Fass, MD (2) · Volodymyr V. Grubnik, Prof., MD (2) · Carlos M Romero, MD (1) · Dariusz Kieszko, MD, PhD (1) · Gao-Jun Teng, MD (1) · Grzegorz Wallner, Professor (1) · Hani Dimassi, PhD (1) · Hong Shan, MD (1) · Hoon Hur, M.D. (1) · Kalapala Rakesh, MD,DM (1) · Krzysztof Zinkiewicz, MD, PhD (1) · Mattijs E Numans, MD, PhD (1) · Mohamad Mroueh, PhD (1) · Mohan Ramchandani (1)
PMID 17085003, PMID 18349316, PMID 24742740, PMID 25887111, PMID 28970956, PMID 34523717, PMID 37142733